Stifel Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $717M | Sell |
779,157
-14,434
| -2% | -$14.6M | 0.66% | 23 |
|
|
2025
Q4 | $853M | Buy |
793,591
+3,424
| +0.4% | +$3.27M | 0.77% | 21 |
|
|
2025
Q3 | $603M | Sell |
790,167
-36,583
| -4% | -$27.2M | 0.55% | 28 |
|
|
2025
Q2 | $645M | Buy |
826,750
+17,121
| +2% | +$13.3M | 0.63% | 23 |
|
|
2025
Q1 | $669M | Buy |
809,629
+10,213
| +1% | +$8.5M | 0.71% | 20 |
|
|
2024
Q4 | $617M | Buy |
799,416
+55,288
| +7% | +$45.8M | 0.64% | 24 |
|
|
2024
Q3 | $659M | Buy |
744,128
+13,925
| +2% | +$12.5M | 0.69% | 23 |
|
|
2024
Q2 | $661M | Buy |
730,203
+2,218
| +0.3% | +$1.77M | 0.74% | 20 |
|
|
2024
Q1 | $566M | Buy |
727,985
+11,669
| +2% | +$8.3M | 0.65% | 23 |
|
|
2023
Q4 | $418M | Buy |
716,316
+15,837
| +2% | +$9.24M | 0.53% | 38 |
|
|
2023
Q3 | $376M | Sell |
700,479
-15,656
| -2% | -$8.07M | 0.53% | 42 |
|
|
2023
Q2 | $336M | Sell |
716,135
-52,411
| -7% | -$22M | 0.46% | 53 |
|
|
2023
Q1 | $264M | Sell |
768,546
-12,419
| -2% | -$4.19M | 0.38% | 69 |
|
|
2022
Q4 | $286M | Buy |
780,965
+29,057
| +4% | +$10.3M | 0.43% | 56 |
|
|
2022
Q3 | $243M | Buy |
751,908
+16,072
| +2% | +$5.09M | 0.4% | 59 |
|
|
2022
Q2 | $239M | Buy |
735,836
+36,438
| +5% | +$10.9M | 0.37% | 63 |
|
|
2022
Q1 | $200M | Buy |
699,398
+68,046
| +11% | +$17.5M | 0.27% | 90 |
|
|
2021
Q4 | $174M | Buy |
631,352
+168,123
| +36% | +$42.6M | 0.23% | 100 |
|
|
2021
Q3 | $107M | Sell |
463,229
-10,862
| -2% | -$2.68M | 0.16% | 145 |
|
|
2021
Q2 | $109M | Buy |
474,091
+37,957
| +9% | +$7.62M | 0.16% | 142 |
|
|
2021
Q1 | $81.5M | Buy |
436,134
+31,433
| +8% | +$6.15M | 0.13% | 162 |
|
|
2020
Q4 | $68.3M | Buy |
404,701
+23,837
| +6% | +$3.56M | 0.12% | 173 |
|
|
2020
Q3 | $56.4M | Buy |
380,864
+33,626
| +10% | +$5.2M | 0.12% | 181 |
|
|
2020
Q2 | $57M | Sell |
347,238
-3,004
| -0.9% | -$461K | 0.13% | 166 |
|
|
2020
Q1 | $48.6M | Sell |
350,242
-5,117
| -1% | -$703K | 0.13% | 170 |
|
|
2019
Q4 | $46.7M | Buy |
355,359
+29,864
| +9% | +$3.46M | 0.1% | 205 |
|
|
2019
Q3 | $36.4M | Sell |
325,495
-40,883
| -11% | -$4.55M | 0.09% | 223 |
|
|
2019
Q2 | $40.6M | Buy |
366,378
+82,005
| +29% | +$9.66M | 0.1% | 202 |
|
|
2019
Q1 | $36.9M | Sell |
284,373
-77,988
| -22% | -$9.48M | 0.1% | 208 |
|
|
2018
Q4 | $42M | Buy |
362,361
+35,500
| +11% | +$3.97M | 0.14% | 168 |
|
|
2018
Q3 | $35.1M | Sell |
326,861
-72,290
| -18% | -$7.23M | 0.1% | 205 |
|
|
2018
Q2 | $34.2M | Sell |
399,151
-13,249
| -3% | -$1.09M | 0.1% | 200 |
|
|
2018
Q1 | $31.9M | Sell |
412,400
-201,823
| -33% | -$16.2M | 0.1% | 209 |
|
|
2017
Q4 | $51.8M | Buy |
614,223
+22,428
| +4% | +$1.91M | 0.16% | 153 |
|
|
2017
Q3 | $50.7M | Sell |
591,795
-31,663
| -5% | -$2.6M | 0.18% | 139 |
|
|
2017
Q2 | $51.3M | Sell |
623,458
-86,245
| -12% | -$7.04M | 0.19% | 122 |
|
|
2017
Q1 | $59.7M | Buy |
709,703
+17,892
| +3% | +$1.43M | 0.23% | 104 |
|
|
2016
Q4 | $50.9M | Sell |
691,811
-10,481
| -1% | -$781K | 0.22% | 110 |
|
|
2016
Q3 | $56.3M | Sell |
702,292
-8,015
| -1% | -$642K | 0.25% | 96 |
|
|
2016
Q2 | $55.9M | Sell |
710,307
-95,041
| -12% | -$7.16M | 0.26% | 96 |
|
|
2016
Q1 | $58M | Sell |
805,348
-2,319
| -0.3% | -$175K | 0.31% | 82 |
|
|
2015
Q4 | $68M | Buy |
807,667
+4,358
| +0.5% | +$362K | 0.35% | 66 |
|
|
2015
Q3 | $67.2M | Sell |
803,309
-13,735
| -2% | -$1.16M | 0.38% | 57 |
|
|
2015
Q2 | $68.2M | Buy |
817,044
+50,379
| +7% | +$3.84M | 0.35% | 60 |
|
|
2015
Q1 | $55.7M | Buy |
766,665
+12,846
| +2% | +$915K | 0.3% | 68 |
|
|
2014
Q4 | $52M | Buy |
753,819
+94,860
| +14% | +$6.4M | 0.29% | 77 |
|
|
2014
Q3 | $42.7M | Buy |
658,959
+260,315
| +65% | +$16.5M | 0.38% | 45 |
|
|
2014
Q2 | $24.8M | Buy |
398,644
+53,376
| +15% | +$3.18M | 0.22% | 105 |
|
|
2014
Q1 | $20.3M | Buy |
+345,268
| New | +$19.3M | 0.19% | 123 |
|
Other funds holding LLY
VCM
VPM
Stifel Financial's LLY Position: Q1 2026 in Review
Stifel Financial reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $14.6M and leaving 779,157 shares worth $717M. The position accounts for 0.66% of the portfolio, ranked #23.
Stifel Financial first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. The position peaked at $853M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Stifel Financial held 779,157 shares of Eli Lilly worth $717M as of Q1 2026.
- Stifel Financial sold 14,434 Eli Lilly shares in Q1 2026, an estimated $14.6M.
- Eli Lilly made up 0.66% of Stifel Financial's portfolio in Q1 2026, its #23 holding.
- Stifel Financial first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Eli Lilly position peaked at $853M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.